Orebro Musculoskeletal Screening Questionnaire-12

January 18, 2022 updated by: Emel Taşvuran Horata, Afyonkarahisar Health Sciences University

Evaluation of Turkish Validity, Reliability and Practicality of Örebro Musculoskeletal System Screening Questionnaire-12

The research is a study with methodological design. The validity, reliability and practicality of the Örebro Musculoskeletal System Screening Questionnaire-12 will be investigated. In this context, a questionnaire will be applied to the participants to take part in the study after the translation process is completed.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Musculoskeletal disorders are quite common in developed and developing countries. Musculoskeletal disorders cause economic burdens in the individual and social field. In addition, getting reports is one of the main causes of reduced productivity and work disability. Therefore, inexpensive and easily applicable screening questionnaires are needed to determine the patient population with high risk musculoskeletal disorders. The Örebro Musculoskeletal Screening Questionnaire is a practical questionnaire that can evaluate musculoskeletal disorders and is tailored to the WHO-ICF themes. For this reason, the aim of the study is to translate the Örebro Musculoskeletal System Survey-12 into Turkish intercultural translation and to investigate the construct validity, reliability and practicality.

Study Type

Observational

Enrollment (Actual)

319

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Afyonkarahisar, Turkey, 03030
        • Emel Taşvuran Horata

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants will be contacted via Google forms after the entire translation process of the questionnaire is completed. Participants will be 18-65 years and have any musculoskeletal problems (spine, upper or lower extremities).

Description

Inclusion Criteria:

  • Having any musculoskeletal problems (spine, upper or lower extremities)
  • Being in the age range of 18-65

Exclusion Criteria:

  • Pregnancy
  • Having of red flag signs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Orebro Musculoskeletal Screening Questionnaire-12
Time Frame: 10 minutes
It is a 12-item self-report questionnaire that aims to estimate a wide range of outcomes (severity of the problem, functional impairment, reporting status, cost and recovery time) in patients with acute and subacute work injury presenting with musculoskeletal pain involving the spine, upper and lower extremities.
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Afyonkarahisar Health Sciences University

Investigators

  • Principal Investigator: EMEL TAŞVURAN HORATA, Afyonkarahisar Health Science University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 18, 2020

Primary Completion (Anticipated)

December 18, 2023

Study Completion (Anticipated)

December 18, 2024

Study Registration Dates

First Submitted

January 17, 2021

First Submitted That Met QC Criteria

January 20, 2021

First Posted (Actual)

January 26, 2021

Study Record Updates

Last Update Posted (Actual)

January 20, 2022

Last Update Submitted That Met QC Criteria

January 18, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2020/469

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Injury

Clinical Trials on Orebro Musculoskeletal Screening Questionnaire-12

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe